dc.rights.license | Restricted to current Rensselaer faculty, staff and students. Access inquiries may be directed to the Rensselaer Libraries. | |
dc.contributor | Bystroff, Christopher, 1960- | |
dc.contributor | Koffas, Mattheos A. G. | |
dc.contributor | Forth, Scott T. | |
dc.contributor | Wang, Chunyu | |
dc.contributor.author | Jordan, Thomas Brown | |
dc.date.accessioned | 2021-11-03T09:22:46Z | |
dc.date.available | 2021-11-03T09:22:46Z | |
dc.date.created | 2021-02-22T15:34:24Z | |
dc.date.issued | 2020-08 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13015/2636 | |
dc.description | August 2020 | |
dc.description | School of Science | |
dc.description.abstract | The global unplanned pregnancy rate remains high (nearly 50%) despite decades of workto provide contraception to all who want it. Contraceptive availability is good, but manyunplanned pregnancies are the result of contraceptive failure or deliberate non-use. An anti-sperm contraceptive vaccine seems likely to have a low failure rate and to be attractive tocurrent non-users because of ease of use, and a nonhormonal, prefertilization mechanism ofaction. This thesis details the expression in E. coliand characterization by transmissionelectron microscopy, of a potential anti-sperm vaccine consisting of the self-assembling ma-jor capsid protein of Human Papillomavirus, L1, chimerically decorated with extracellularfragments of the sperm specific calcium channel, CatSper, which is necessary for fertility. L1is well suited to be a scaffold for vaccine design because of the size, structure and stabilityof the particles it spontaneously forms, This is the first use of L1 as a scaffold for the pre-sentation of non-viral antigens, and may help pave the way for a broader adoption of L1 asa standardized scaffold for vaccine design. | |
dc.language.iso | ENG | |
dc.publisher | Rensselaer Polytechnic Institute, Troy, NY | |
dc.relation.ispartof | Rensselaer Theses and Dissertations Online Collection | |
dc.subject | Biology | |
dc.title | Production and characterization of chimeric human papillomavirus l1 virus-like particles for use as a contraceptive vaccine | |
dc.type | Electronic thesis | |
dc.type | Thesis | |
dc.digitool.pid | 180402 | |
dc.digitool.pid | 180404 | |
dc.digitool.pid | 180405 | |
dc.rights.holder | This electronic version is a licensed copy owned by Rensselaer Polytechnic Institute, Troy, NY. Copyright of original work retained by author. | |
dc.description.degree | PhD | |
dc.relation.department | Dept. of Biological Sciences | |